Activation state (phosphorylated) EGFR and STAT3 as prognostic markers in resected non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Cortas, T [1 ]
Eisenberg, R [1 ]
Fu, P [1 ]
Robke, J [1 ]
Kern, JA [1 ]
Dowlati, A [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：642S / 642S
页数：1
相关论文
共 50 条
  • [31] SphK1 promotes development of non-small cell lung cancer through activation of STAT3
    Ma, Yuefeng
    Xing, Xin
    Kong, Ranran
    Cheng, Chuantao
    Li, Suoni
    Yang, Xiaoping
    Li, Shaomin
    Zhao, Feng
    Sun, Liangzhang
    Cao, Gang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (01) : 374 - 386
  • [32] MALDI-MS derived prognostic protein markers for resected non-small cell lung cancer
    Xu, Baogang J.
    Gonzalez, Adriana L.
    Kikuchi, Takefumi
    Yanagisawa, Kiyoshi
    Massion, Pierre P.
    Wu, Huiyun
    Mason, Stephen E.
    Olson, Sandy J.
    Shyr, Yu
    Carbone, David P.
    Caprioli, Richard M.
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (10-11) : 1508 - 1517
  • [33] Prognostic molecular markers in non-small cell lung cancer
    Niklinski, J
    Niklinska, W
    Laudanski, J
    Chyczewska, E
    Chyczewski, L
    LUNG CANCER, 2001, 34 : S53 - S58
  • [34] Prognostic markers in resectable non-small cell lung cancer
    Strauss, GM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (03) : 409 - &
  • [35] Prognostic Immune Markers in Non-Small Cell Lung Cancer
    Suzuki, Kei
    Kachala, Stefan S.
    Kadota, Kyuichi
    Shen, Ronglai
    Mo, Qianxing
    Beer, David G.
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5247 - 5256
  • [36] Hunting for transcription factors: STAT3 decoy in non-small cell lung cancer
    Carmicheal, Joseph
    Kaur, Sukhwinder
    Batra, Surinder K.
    Ganti, Apar Kishor
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S254 - S257
  • [37] EGFR mutation and p-EGFR expression in resected Non-Small Cell Lung Cancer
    Liu Wei
    McMillen, Elizabeth
    Ye Fei
    Li Guanghu
    Wu Yong
    Yin Guanghao
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S916 - S916
  • [38] Hypoxic markers in non-small cell lung cancer (NSCLC) - A review
    Xu, F. -X.
    Zhang, Y. -L.
    Liu, J. -J.
    Zhang, D. -D.
    Chen, H. -B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (05) : 849 - 852
  • [39] Prognostic factors in synchronous solitary resected brain metastasis from non-small cell lung cancer (NSCLC)
    Louie, A.
    Rodrigues, G.
    Yaremko, B.
    Yu, E.
    Dar, R.
    Dingle, B.
    Vincent, M.
    Sanatani, M.
    Younus, J.
    Malthaner, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S455 - S455
  • [40] Prevalence, Prognostic Implications and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer (NSCLC) in the US
    Osarogiagbon, Raymond U.
    Lin, Chun C.
    Smeltzer, Matthew P.
    Jemal, Ahmedin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S241 - S241
12345